P

Pfizer

Makes cancer drugs, vaccines and other medicines

Production Lead 1

Full-TimeDeadline 10/22/26
$25.66 - $42.76/hr+ Overtime pay + Weekend pay premiums + Holiday pay premiums + Other pay premiums
Mid
Kalamazoo, MI, USA
In PersonOn-site role with a variable shift; initial training is on first shift before moving to second shift.
Manufacturing & Production Operations
No H1B Sponsorship

About the job

Requirements
  • A high school diploma or GED is required.
  • At least 4 years of experience is required.
  • Proficiency in Good Manufacturing Practices (GMP) and related systems is required.
  • Ability to troubleshoot and resolve technical issues is required.
  • Strong organizational skills and attention to detail are required.
  • Ability to work independently and as part of a team is required.
  • Ability to adapt to changing priorities and manage multiple tasks is required.
  • Ability to communicate effectively across departments and follow written and verbal instructions is required.
  • Candidates must be authorized to be employed in the United States by any employer and must have permanent work authorization in the United States.
  • The role requires lifting and lowering up to 55 pounds; standing, walking, sitting, climbing, reaching, stooping, and working at elevated heights; and responding effectively to changing operational conditions while maintaining compliance and safety.
  • The role requires work in manufacturing, cleanroom (Grade A/B/C/D), and office environments, with gowning and personal protective equipment such as a hard hat, body harness, face shield, and hearing and eye protection.
  • Candidates must be available for a second-shift schedule of 2:30 PM–11:30 PM and an initial training period on first shift, 6:30 AM–3:30 PM, for several months.
  • The role may require nights, weekends, holidays, overtime, and non-standard schedules based on business needs.
Responsibilities
  • Lead day-to-day manufacturing operations to meet production schedules while ensuring compliance with standard operating procedures, Good Manufacturing Practices, Occupational Safety and Health Administration requirements, and Pfizer standards.
  • Liaise among operations, maintenance, technical support, logistics, planning, and management to resolve production issues and adjust plans as needed.
  • Monitor, evaluate, and improve manufacturing processes and equipment using IMEx, Right First Time, Method 1, 5S, Lean, and continuous improvement principles.
  • Serve as a technical expert and role model on the shop floor, supporting troubleshooting, investigations (M1s, QARs, and deviations), and root cause analysis.
  • Support training compliance by ensuring team members are trained and qualified for their roles; mentor and develop colleagues and provide feedback to leadership.
  • Represent the operations area in audits, capital projects, new product introductions, equipment qualification activities (IQ/OQ/PQ, FAT/SAT), and continuous improvement initiatives.
  • Partner with planning to allocate manpower and resources to meet production commitments and respond to changing business priorities.
  • Maintain accurate documentation, generate work orders and reports, and ensure audit readiness.
  • Communicate with production teams and leadership and model Pfizer values and leadership behaviors.
  • Provide leadership and direction to meet production demands across Drug Product Operations, including formulation, filling, freeze dry, packaging, inspection, aseptic services, biological operations, and other manufacturing units.
  • Serve as a liaison between shop floor operators, unit leadership, and cross-functional partners to support safe, compliant, and efficient operations.
  • Model Good Manufacturing Practice behaviors, ownership, and teamwork to ensure production activities meet regulatory, safety, quality, and business requirements.
Desired Qualifications
  • Experience in pharmaceutical manufacturing or a related field is preferred.
  • Knowledge of regulatory requirements and quality standards, including current Good Manufacturing Practices, is preferred.
  • Experience with Lean Manufacturing principles is preferred.
  • Familiarity with Pfizer's Learning Solution and Quality Tracking System is preferred.
  • Ability to train and mentor less-experienced colleagues is preferred.
  • Familiarity with common artificial intelligence tools and curiosity about using them to enhance productivity are preferred.

About the company

Pfizer discovers, makes, and sells prescription medicines and vaccines for patients, doctors, and governments worldwide, with large businesses in vaccines, cancer, heart disease, and rare diseases. In 2020, its COVID-19 shot, developed with German partner BioNTech, became the first COVID-19 vaccine authorized in the United States. Its scientists find drug candidates and run clinical trials to prove they are safe and effective, and Pfizer then manufactures approved products in its own plants, earning most of its money from patented drugs before cheaper generic copies arrive. Pfizer was founded in 1849 as a chemicals business in Brooklyn and is based in New York City.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Get referred to Pfizer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Newer drugs carry the business: launched and acquired products grew 18% operationally in Pfizer's August 2026 quarterly report.
  • The outlook improved: in August 2026, Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion.
  • Vaccine scientists get room to grow: Pfizer's $470 million Pearl River, New York research expansion is designed for 370 workers.

What critics are saying

  • Expect more site cuts: in November 2025, Pfizer moved to shrink Swiss staff from about 300 to roughly 70.
  • Generics will erase sales: Pfizer expects patent losses to cut $17 billion to $18 billion of yearly revenue through 2028.
  • Pfizer is chasing obesity leaders: Metsera's monthly shot showed 12.3% weight loss at 28 weeks in February 2026 data.

What makes Pfizer unique

  • Pfizer bought its way into cancer: its Seagen buyout added antibody-drug conjugates, which carry chemotherapy straight to tumors.
  • Pfizer is betting on monthly obesity shots: Metsera's berobenatide is dosed once a month, unlike weekly Wegovy and Zepbound.
  • Pfizer leans on one partnered heart drug: blood thinner Eliquis, sold with Bristol Myers Squibb, brings about 14% of revenue.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-3%

2 year growth

-3%
Yahoo Finance
Oct 19th, 2026
Five low-beta dividend stocks: Pfizer yields 5.83%, Coca-Cola raises payout since 1999

Five defensive dividend stocks offer income with less volatility than the broader market, according to a 24/7 Wall St. analysis. All five have a beta well below 1, meaning they have historically moved less than the market. Pfizer leads with a forward yield of 5.83% at $29.49 a share. AT&T yields 4.77% at $23.27, and its $1.11 dividend uses about 42% of 2026 free cash flow guidance of $18B+. Debt of $144B is its main risk. Dominion Energy yields 4.24%, while Coca-Cola and Colgate-Palmolive each yield 2.27%. Coca-Cola has raised its dividend every year since 1999, and Colgate's next ex-dividend date is October 20, 2026.

Yahoo Finance
Oct 15th, 2026
GSK beats Pfizer as dividend stock: 39% payout vs 89% of free cash flow

GSK looks the better dividend stock than Pfizer, according to a comparison of the two drugmakers, which both face major patent losses before 2030. Pfizer yields 6.3% and GSK 4.1%. Over the twelve months to June 2026, Pfizer paid out 89% of its free cash flow in dividends ($9.79 billion of $10.98 billion), against 39% at GSK (£2.67 billion of £6.90 billion). Pfizer's chief executive officer, Albert Bourla, said the dividend will be maintained even in "the most stretched scenarios." Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion. GSK raised its dividend 17.6% in fiscal 2025 after an earlier cut, and Q2 2026 sales rose 5%. Its main risk is debt: net debt rose to £22 billion after the Nuvalent acquisition.

Yahoo Finance
Oct 14th, 2026
Pfizer's 6% dividend pays investors to wait as oncology pipeline drives growth beyond COVID-19

Pfizer offers a dividend yield of just over 6% while it builds growth beyond its COVID-19 products. The drugmaker declared a quarterly dividend of $0.43 in June 2026, its 351st consecutive quarterly payment. In the second quarter, revenue from launched and acquired products rose 18% year over year. Pfizer raised the midpoint of its full-year guidance, helped by stronger non-COVID sales from drugs such as Eliquis, Padcev, and Vyndaqel. Oncology is the next focus. Pfizer is investing in antibody-drug conjugates and bispecific antibodies, and it entered a global collaboration with Innovent Biologics covering 12 early-stage cancer programs. Not every experimental drug will succeed, but a broader pipeline improves the odds. If new medicines work, the share price could rise on top of the dividend income.

Yahoo Finance
Oct 13th, 2026
Six high-yield dividend stocks fail the payout test, from Ford to Whirlpool's 9.37% mirage

High dividend yields can hide weak payouts, and a four-step test helps separate real income from traps. It checks earnings with one-offs stripped out, full-year free cash flow against dividends, management's explanation, and whether debt funds the gap. Ford yields 4.99% and shows a trailing EPS of -$1.88, caused by $4.2B in one-time charges. Its debt-to-equity of 4.66 leaves the $0.60 dividend exposed to a downturn. Pfizer yields 6.03%, but its free cash flow yield is 5.60%. Clorox's roughly $405M of free cash flow fell short of about $601M in dividends. Whirlpool fails every step. It cut its quarterly dividend from $1.75 to $0.90 in 2025, paid no common dividend in the second quarter of 2026, and its shares are down 59.48% since the end of 2025. 3M and Dow pass, with payouts now covered by cash.

Yahoo Finance
Oct 12th, 2026
UPS, Pfizer, Kraft Heinz and Ford dividends at risk as payouts outstrip earnings

Four blue chip companies, UPS, Pfizer, Kraft Heinz, and Ford, may struggle to sustain their dividends, according to an analysis of their earnings, cash flow, and debt. UPS yields 7.02% and pays out about 121% of its GAAP earnings. Pfizer yields 6.10%, with a GAAP payout ratio of about 226%; its 2025 free cash flow of $9.076 billion fell short of $9.771 billion in dividends. Kraft Heinz yields 6.82%, but its trailing GAAP earnings per share are −$2.88 after $7.4 billion in impairments. Ford yields 4.98% after an $8.162 billion loss in 2025, and its debt-to-equity ratio is 4.66. All four companies say their payouts are safe, and each points to adjusted earnings guidance that covers the dividend.